Stigma Follows Lung Cancer Nonsmokers, Such As Actress Dana Reeve, Also Get Deadly Disease Lung Cancer is the World's Top Cancer Killer
Posted on: Wednesday, 10 August 2005, 18:00 CDT
Lung cancer is top cancer killer worldwide, but treatments are improving. Landmark studies in the past two years found that chemotherapy can improve survival, and a large study is under way to see whether screening smokers for the disease can prevent deaths.
INCIDENCE: Estimated cases are 172,500 in the United States, more than 1.3 million worldwide each year.
DEATHS: 163,510 are expected in the U.S. this year, and nearly 1.2 million worldwide.
SURVIVAL: At five years, 49 percent when cancer is confined to the lung; 16 percent if it has spread within the chest, and 2 percent if it has spread to other organs.
TREATMENT: Surgery is the first choice; chemotherapy and radiation also can be used. Chemotherapy is sometimes given before surgery to shrink tumors.
DETECTION: No screening tests are recommended.
SYMPTOMS: Persistent cough, coughing up blood, chest pain, recurring pneumonia.
Sources: American Cancer Society, World Health Organization.
Source: Advocate; Baton Rouge, La.
Related Articles
- Exercise Reduces Fatigue In Cancer Patients Undergoing Chemotherapy
- Elderly Breast Cancer Patients Receive Chemotherapy If Treated In Private Clinics
- New Data Support Use of Simple Test to Predict Endometrial Cancer Response to Chemotherapy
- Scientists Discover How Cancer Cells Survive Chemotherapy Drug
- Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients With Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
- Chicago Area Nonprofit Fills Unique Niche for Low-Income Cancer Patients During Chemotherapy
- Affymax Presents Results From Ongoing Phase 2 Clinical Trial of Hematide(TM) in Anemic Cancer Patients Receiving Chemotherapy
- Teen With Cancer Can Forgo Chemotherapy
- Lung Cancer Most Common Cancer Worldwide
- The National Surgical Adjuvant Breast and Bowel Project (NSABP) and Genomic Health, Inc. Announce Positive Study Results Demonstrating Oncotype DX Genomic Breast Cancer Assay Predicts Chemotherapy Response
User Comments (0)

RSS Feeds